Effective suppression of atrial fibrillation by ivabradine: Novel target for an established drug?

In the present experimental study, administration of ivabradine reduced inducibility of AF and therefore may represent a supplemental therapeutic option in AF. Of note, its antiarrhythmic efficacy was comparable to the established agent flecainide.